The responsiveness of enterocytes to Escherichia coli heat-labile enterotoxin (LT) was studied in the small intestine of 6-to 7-week-old rats. Dose-effect analysis showed the dose required for a 50% maximal LT-induced secretory response to be at 8 nM. After the well-documented glycolipid GM1 receptor was blocked with the cholera toxin B subunit, LT still activated the second messenger cascade, measured in terms of heightened cellular adenylate cyclase activity, and caused fluid to be secreted into ligated intestinal loops. Furthermore, Scatchard analysis of binding kinetics suggested that LT bound to two receptor sites on the intestinal microvillus membrane. The toxin also bound to delipidated membrane but was competitively inhibited by a galactose-specific lectin, RCA60, suggesting that the additional receptor is a galactoglycoprotein. Western blot analysis of toxin binding to membrane proteins revealed a group of binding components around 85 to 150 kilodaltons. When measured at 2.2 nM LT, approximately 70% of LT-binding activity took place through a high-affinity (Kdl, 0.38 nM) GM1 receptor and 30% of LT-binding activity took place through a low-affinity (Kd2, 3.3 nM) glycoprotein receptor. These results suggest that LT functions through two microvillus membrane receptors in the mature rat small intestine.
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Enterotoxigenic Escherichia coli produces the heat-labile enterotoxin (LT) that causes diarrhea in humans (31) and in animals (34) . The E. coli LT affecting humans is a 91,400-dalton protein (6) whose structure, biological activity, and antigenic determinants closely resemble those of Vibrio cholerae enterotoxin (CT) (5, 8) .
Like CT (9, 26) , LT is a heterohexamer (13) made up of five B subunits, which bind to the glycolipid GM1 receptor (17) on the surface of the intestinal epithelium, and a single A subunit, which crosses the cell membrane, ADP ribosylates the Gs subunit of the GTP-binding regulatory protein (14) , activates adenylate cyclase (EC 4.6.1.1) (10) , and disrupts ion transport across the epithelial membrane, causing net fluid secretion (11) .
However, unlike CT, LT binds an additional glycoprotein receptor on the surface of rabbit (15, 19, 30) and human (18) intestine. The glycoprotein receptor has not been previously observed in the rat intestine. Furthermore, a dose-effect relationship between the purified LT and its natural host target tissue, the small intestine, has not been adequately characterized.
In this study we have attempted to quantify the responsiveness of the rat intestine to LT. We have also tried to characterize the glycoprotein receptors and to assess their contribution in the diarrheal effect of the toxin. The rats were chosen because they were useful models in our earlier investigation of the development of the intestinal host defense against CT (3, 22, 33) . Previous studies have indicated that a mature intestine is less susceptible than an immature intestine to CT infection (3, 33) . The data obtained in this study may be used to compare the relative sensitivity of the host to CT and LT and to provide information for subsequent developmental studies. Bacterial toxins. LT isolated from a genetically constructed strain, MM294(pWD600) (23) , which was cloned from a human enterotoxigenic strain of E. coli (H74-114) (12) , was generously donated by R. A. Finkelstein (Department of Microbiology, University of Missouri, Columbia). CT and the pentamer of cholera toxin B subunit (choleragenoid; CT-B) were purchased from List Biological Laboratories (Campbell, Calif.).
Intestinal loop assay. Female 6-to 7-week-old rats, weighing 150 to 175 g, were fasted for 18 h. The animals were anesthetized with ether. Two 5-cm loops were ligated on the proximal small intestine, and two were ligated on the distal small intestine. One loop in each pair was injected with toxin in 0.5 ml of phosphate-buffered saline (136 mM NaCl, 2.6 mM KCl, 8 mM Na2HPO4, and 1.5 mM KH2PO4 [pH 7.3]), containing 0.1% bovine serum albumin; the other loop was injected with phosphate-buffered saline-bovine serum albumin buffer (control). Net fluid accumulation in the two toxin-treated loops was determined 4 h after the toxin was administered and is expressed as microliters per centimeter of gut length. The dose required for a 50% maximal response (ED50) was estimated by using a dose-effect analysis (2) program (Elsevier-Biosoft, Cambridge, United Kingdom) on an IBM personal computer. In blocking the toxin-induced fluid secretion, a 100-fold excess of CT-B was used. The CT B subunit was introduced into the appropriate loops 3 18 -fold increase in sucrase activity (7) . MVM lipid was extracted twice, each time with 20 volumes of chloroform-methanol-water (4:8:3, vol/vol/vol) (35) . The mixture was centrifuged at 2,000 x g for 10 min. The resulting delipidated MVM pellets along with native MVM preparations were suspended by homogenization in 10 mM Tris hydrochloride containing 1 mM EGTA (pH 7.4) and used for the toxin-binding assay.
Toxin iodination. The toxin was iodinated with lodo-beads (Pierce Chemical Co., Rockfold, Ill.) as described by Mark- Detection of a glycoprotein receptor by Western blots. MVM was separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis by the method of Laemmli (21) under reducing conditions on a 5 to 15% gradient acrylamide gel and transferred by electroblotting (36) (Fig. 1) . A lag phase occurred because the LT A subunit entered the epithelial cell from the intestinal lumen and had to translocate to the basal-lateral membrane, where it constitutively activated the Gs protein, leading to induction of adenylate cyclase. There was no significant different in the net amount of fluid secreted into the proximal and the distal loops in response to LT. Data obtained from both gut regions were pooled to construct the dose-response curve (Fig. 2) . The results show that the LT-induced secretory response is dose dependent. The maximal effective dose, 55 nM LT (5 ,ug/ml), cholera toxin, specifically binds the microvillus receptor, ganglioside GM1, but has no secretory effect on the intestine. In fact, an excess of this subunit completely inhibited the CT effect on the intestine when 60 nM of CT, a dose (3) known to produce maximal secretory response (205 ± 48 ,ul/cm over 4-h period), was used. If LT only recognized the ganglioside GM1, an excess of CT-B would inhibit its action, and no fluid would be expected to accumulate in the ligated loop. However, if LT recognized a different or an additional membrane receptor, net fluid accumulation in the loop should be reduced or uninhibited. We noted a reduction in the amount of fluid that accumulated in loops pretreated with CT-B subunit (Fig. 2) . Furthermore, the results show a more effective inhibition of the LT effect (-70%) at lower toxin doses (-1 to 5 nM), a less effective inhibition (-30%) at higher doses (-20 to 40 nM), and no inhibition beyond the maximal effective doses (>55 nM). These findings suggest that LT recognized GM1 as well as an additional receptor(s).
Dose-dependent activation of adenylate cyclase. The absolute adenylate cyclase activity in control and LT-stimulated intestinal loops was difficult to determine since variation from animal to animal was substantial. However, when loops from the same animal were compared, a consistent two-to threefold induction of adenylate cyclase activity was seen in loops treated with LT (Fig. 3) . Adenylate cyclase activity also seemed to respond to an increase in the toxin dose, with the maximum activity (20 pmol of cyclic AMP produced per min pre mg of membrane protein) reached at 55 nM LT (5 jig/ml). This toxin dose also led to maximal fluid secretion.
Effect of CT B-subunit blocking on adenylate cyclase activation. We assayed the adenylate cyclase activity of ligated loops where the toxin effect was partially inhibited by a pretreatment with CT-B (Fig. 3) . The cyclase activity in these loops was below the levels in loops treated with LT alone. At the same time, this enzyme activity was significantly above the basal level. In fact, the pattern of adenylate cyclase activity in loops treated with LT and with LT plus CT-B was similar to the pattern of net fluid accumulation in these loops. At lower toxin doses, CT-B was able to maintain adenylate cyclase activity close to the basal level, whereas at higher doses, the inhibition of activities was less successful, and near-maximal cyclase activity resulted. These findings are not surprising if we consider that adenyl- adenylate cyclase activity support a multireceptor model according to which, when GM1 has been blocked, LT at high doses acts through an alternate low-affinity receptor(s) to activate the enzyme.
Binding of LT to MVM. MVM preparations and 125I-labeled LT were used to study the binding kinetics of toxin receptors in the rat small intestine. The binding of LT to MVM was dose dependent and saturable (Fig. 4) . Scatchard analysis (32) of the binding data (Fig. 5) suggests the existence of two classes of receptors (Kdl, 0.38 nM; Bmaxi, 12.5 pmol/mg of protein; Kd2, 3.3 nM, Bmax2, 17.5 pmol/mg of protein). The high-affinity receptor corresponds to the ganglioside GM1.
Binding of LT to delipidated MVM. To estimate the contribution of the additional receptor sites, glycolipids were extracted from the MVM. Comparison of the binding of LT to native and delipidated membrane fractions showed that GM1 was responsible for approximately 70 to 80% of LT binding ( Table 1) . The results also indicated that the specific binding of LT to delipidated MVM, like its binding to native MVM, was dose dependent (Table 1) , with 2.6 pmol of LT bound per mg of protein at a low toxin dose (0.55 nM) and 5.2 pmol of LT bound at a high toxin dose (2.2 nM). Thus, these data suggest that, in addition to GM1, LT may be binding a single glycoprotein receptor or a family of receptors that exhibits low affinity for the toxin.
Competition analysis of LT binding to delipidated MVM.
Ricinus communis agglutinin (RCA60), a galactose-specific lectin, successfully competed with radiolabeled LT for binding to delipidated MVM ( (Fig. 7) . A prominent band with low molecular mass at a dye front corresponding to ganglioside GM1 was present in all of the membrane preparations. Several smaller bands with molecular masses around 85 to 150 kilodaltons were probably membrane glycoproteins. More binding components were detected in the distal MVM than in the proximal MVM prepared from the mature intestine, but no protein band was detected in a 2-week-old neonatal intestine.
DISCUSSION
The findings presented in this study show that a functional galactoglycoprotein heat-labile enterotoxin receptor site exists on the rat intestinal epithelium. Similar studies conducted on rabbit (15, 19, 30) and human (18) intestine have also pointed to the existence of such a site in addition to the well-documented ganglioside GM1 receptor.
The toxin, which causes secretory diarrhea by activating an adenylate cyclase-dependent second messenger pathway in the enterocyte, is known to act through the GM1. The data in this study show that the diarrheal effect of the toxin in ligated intestinal loops persisted even when the GM1 had been blocked. It has also been observed that the fluid secretion is dose dependent in both blocked and nonblocked loops. However, the pattern of fluid secretion is different in the two systems. In the loops blocked with CT B subunit, less fluid was secreted at the lower toxin doses; whereas at the higher doses, similar amounts of fluid collected in both types of loops. These findings suggest that a glycoprotein LT receptor(s) might have a lower affinity for the toxin than the GM1. Scatchard analysis supports this conclusion. Because of the difference in receptor affinity, naturally occurring quantities of toxin most likely are affecting the epithelium primarily through the GM1 in the rat intestine. This study also indicates that, in causing fluid secretion, LT activates the adenylate cyclase second messenger cascade. Dose-dependent activation of adenylate cyclase was seen in the mucosal samples of CT-B-blocked and nonblocked intestinal loops. In all instances, however, the nonblocked samples exhibited higher adenylate cyclase activity.
The receptor-binding studies also support a two-receptor model. Scatchard analysis of LT binding to the native MVM was characteristic of two receptors, whereas a similar binding of CT to the MVM of rat intestine suggested only one receptor (3, 22) . LT bound specifically to the delipidated MVM, suggesting that the additional LT receptor was a glycoprotein. Furthermore, galactose-specific lectin (RCA60) inhibited LT binding to delipidated MVM, suggesting that the additional receptor has galactose residues essential for toxin binding. Finally, Western blot analysis of LT binding proved that the toxin associated with membrane proteins of a large molecular mass (85 to 150 kilodaltons) along with the small molecular glycolipid GM1.
The significance of the multi-band pattern of toxin-binding proteins remains to be elucidated. However, there is some indication that the pattern depends upon the age of the animal and the region of the small intestine. These data probably can be explained by the previous finding that the expression of cell-surface galactose on MVM is developmentally (29) and regionally (27) regulated in the rat small intestine. The multi-band pattern might possibly reflect the lectinlike binding of LT to MVM. Such binding characteristics have been noted with the pertussis toxin binding to Chinese hamster ovary cells (1) . Since the membrane components were separated under reducing conditions, it is also possible that the bands might represent subunits of a single polypeptide receptor that binds LT. The ratio of glycolipid GM1 and glycoprotein receptors for LT in the small intestine appears to vary from species to p.. species. For example, about 50% of the receptor sites for LT in the human intestine are glycoprotein (18) , whereas in rabbit intestine, glycoprotein receptor sites appear to outnumber the GM1-binding sites by more than 10-fold (19) . Our data show that, in rat intestine, about 30% of the receptor sites are contributed by delipidated MVM (glycoprotein) when measured with 2.2 nM LT. Comparison of these data indicates that the ratio of the two toxin receptors in humans is much closer to that in rats than to that in rabbits. Thus, the rat seems to serve as a better animal model than the rabbit for the study of LT interaction with the enterocyte.
The biological efficacy of LT was compared with that of CT (3), in terms of the relative sensitivity of the mature rat intestine to the two enterotoxins. The data show that, on a molar basis, LT (ED50, 8 nM) was more effective than CT (ED50, 38.9 nM) in triggering a stimulus-secretory response, although both LT and CT bound to GM1 with equally high affinity (Kd, 0.38 and 0.42 nM, respectively). Furthermore, when the ratio of Kd to ED50 was used as an estimate of coupling efficiency for initial receptor binding to the final secretory response, the coupling efficiency was higher for LT (5%) than for CT (1%). Therefore, the difference in the host responsiveness to these two toxins seemed to be related to postreceptor events, not to the initial receptor occupancy. A similar finding was previously noted for the increased sensitivity in the host responsiveness to CT of the immature suckling rat (3) . Whether developmental changes alter the host responsiveness of LT is under investigation.
